Skip to main content

Advertisement

Open Peer Review Reports for: Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

Back to article

Pre-publication versions of this article are available by contacting editorial@trialsjournal.com.

Original Submission
2 Nov 2017 Submitted Original manuscript
22 Nov 2017 Reviewed Reviewer Report - Singal AK
26 Jan 2018 Author responded Author comments - Bjørn Madsen
Resubmission - Version 2
26 Jan 2018 Submitted Manuscript version 2
4 Feb 2018 Reviewed Reviewer Report - Singal AK
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
4 Feb 2018 Editorially accepted
26 Feb 2018 Article published 10.1186/s13063-018-2523-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement